111 related articles for article (PubMed ID: 16314052)
21. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation.
Shimizu S; Nagasawa T; Katoh O; Komatsu N; Yokota J; Morishita K
Biochem Biophys Res Commun; 2002 Apr; 292(3):609-16. PubMed ID: 11922610
[TBL] [Abstract][Full Text] [Related]
22. EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22.
De Weer A; Speleman F; Cauwelier B; Van Roy N; Yigit N; Verhasselt B; De Moerloose B; Benoit Y; Noens L; Selleslag D; Lippert E; Struski S; Bastard C; De Paepe A; Vandenberghe P; Hagemeijer A; Dastugue N; Poppe B;
Haematologica; 2008 Dec; 93(12):1903-7. PubMed ID: 18815193
[TBL] [Abstract][Full Text] [Related]
23. Enhanced sensitivity to hydrogen peroxide-induced apoptosis in Evi1 transformed Rat1 fibroblasts due to repression of carbonic anhydrase III.
Roy P; Reavey E; Rayne M; Roy S; Abed El Baky M; Ishii Y; Bartholomew C
FEBS J; 2010 Jan; 277(2):441-52. PubMed ID: 20015077
[TBL] [Abstract][Full Text] [Related]
24. Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.
Vinatzer U; Mannhalter C; Mitterbauer M; Gruener H; Greinix H; Schmidt HH; Fonatsch C; Wieser R
Genes Chromosomes Cancer; 2003 Jan; 36(1):80-9. PubMed ID: 12461752
[TBL] [Abstract][Full Text] [Related]
25. Conservation and expression of a novel alternatively spliced Evi1 exon.
Alzuherri H; McGilvray R; Kilbey A; Bartholomew C
Gene; 2006 Dec; 384():154-62. PubMed ID: 17014970
[TBL] [Abstract][Full Text] [Related]
26. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract][Full Text] [Related]
27. Leukemogenesis of the EVI1/MEL1 gene family.
Morishita K
Int J Hematol; 2007 May; 85(4):279-86. PubMed ID: 17483069
[TBL] [Abstract][Full Text] [Related]
28. The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.
Senyuk V; Li D; Zakharov A; Mikhail FM; Nucifora G
Cancer Res; 2005 Sep; 65(17):7603-11. PubMed ID: 16140925
[TBL] [Abstract][Full Text] [Related]
29. Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide.
Shackelford D; Kenific C; Blusztajn A; Waxman S; Ren R
Cancer Res; 2006 Dec; 66(23):11360-9. PubMed ID: 17145882
[TBL] [Abstract][Full Text] [Related]
30. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
Storlazzi CT; Anelli L; Albano F; Zagaria A; Ventura M; Rocchi M; Panagopoulos I; Pannunzio A; Ottaviani E; Liso V; Specchia G
Ann Hematol; 2004 Feb; 83(2):78-83. PubMed ID: 14551738
[TBL] [Abstract][Full Text] [Related]
31. Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice.
Louz D; van den Broek M; Verbakel S; Vankan Y; van Lom K; Joosten M; Meijer D; Löwenberg B; Delwel R
Leukemia; 2000 Nov; 14(11):1876-84. PubMed ID: 11069022
[TBL] [Abstract][Full Text] [Related]
32. Development of megakaryoblastic leukaemia in Runx1-Evi1 knock-in chimaeric mouse.
Maki K; Yamagata T; Yamazaki I; Oda H; Mitani K
Leukemia; 2006 Aug; 20(8):1458-60. PubMed ID: 16761014
[No Abstract] [Full Text] [Related]
33. Physical and functional interaction of the proto-oncogene EVI1 and tumor suppressor gene HIC1 deregulates Bcl-xL mediated block in apoptosis.
Pradhan AK; Halder A; Chakraborty S
Int J Biochem Cell Biol; 2014 Aug; 53():320-8. PubMed ID: 24907396
[TBL] [Abstract][Full Text] [Related]
34. [Pathogenetic significance of deregulated hematopoietic transcription factors in leukemia--Evi-1 as a critical regulator for hematopoiesis and leukemia].
Kurokawa M
Rinsho Ketsueki; 2009 Mar; 50(3):168-73. PubMed ID: 19352083
[No Abstract] [Full Text] [Related]
35. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development.
Hoyt PR; Bartholomew C; Davis AJ; Yutzey K; Gamer LW; Potter SS; Ihle JN; Mucenski ML
Mech Dev; 1997 Jul; 65(1-2):55-70. PubMed ID: 9256345
[TBL] [Abstract][Full Text] [Related]
36. [The pathogenetic significance of deregulated hematopoietic transcription factors in leukemia].
Kurokawa M
Rinsho Ketsueki; 2007 Oct; 48(10):1388-92. PubMed ID: 17933124
[No Abstract] [Full Text] [Related]
37. EVI1-mediated Programming of Normal and Malignant Hematopoiesis.
Lux S; Milsom MD
Hemasphere; 2023 Oct; 7(10):e959. PubMed ID: 37810550
[No Abstract] [Full Text] [Related]
38. Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancer.
Xu X; Liu S; Ji X
Onco Targets Ther; 2017; 10():2739-2744. PubMed ID: 28603423
[TBL] [Abstract][Full Text] [Related]
39. New functions for ecotropic viral integration site 1 (EVI1), an oncogene causing aggressive malignant disease.
Wieser R
Cell Cycle; 2012 Nov; 11(21):3915. PubMed ID: 23032258
[No Abstract] [Full Text] [Related]
40. EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer.
Kim HR; Yim J; Yoo HB; Lee SE; Oh S; Jung S; Hwang CI; Shin DM; Kim T; Yoo KH; Kim YS; Lee HW; Roe JS
NAR Cancer; 2021 Jun; 3(2):zcab023. PubMed ID: 34316710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
